Metagenomi, Inc. (MGX)
NASDAQ: MGX · Real-Time Price · USD
1.740
+0.040 (2.35%)
At close: Nov 14, 2025, 4:00 PM EST
1.839
+0.099 (5.67%)
After-hours: Nov 14, 2025, 7:52 PM EST
Metagenomi Market Cap
Metagenomi has a market cap or net worth of $65.31 million as of November 14, 2025. Its market cap has decreased by -16.91% in one year.
Market Cap
65.31M
Enterprise Value
-96.70M
1-Year Change
-16.91%
Ranking
Category
Stock Price
$1.74
Market Cap Chart
Since the IPO on February 9, 2024, Metagenomi's market cap has decreased from $562.92M to $65.31M, a decrease of -88.40%. That is a compound annual growth rate of -70.50%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 14, 2025 | 65.31M | -51.66% |
| Dec 31, 2024 | 135.10M | -76.00% |
| Feb 9, 2024 | 562.92M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 918.02B |
| Johnson & Johnson | 472.05B |
| AbbVie | 410.67B |
| UnitedHealth Group | 291.55B |
| AstraZeneca | 276.16B |
| Novartis AG | 252.58B |
| Merck & Co. | 230.63B |
| Abbott Laboratories | 227.08B |